Your browser doesn't support javascript.
loading
Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer's Disease.
Lee, Na Kyung; Myeong, Su Hyeon; Hwang, Jung Won; Sa, Jason K; Son, Hyo Jin; Kim, Hee Jin; Jang, Hyemin; Chang, Jong Wook; Na, Duk L.
Affiliation
  • Lee NK; School of Medicine, Sungkyunkwan University, Suwon 16419, Korea.
  • Myeong SH; Samsung Medical Center, Cell and Gene Therapy Institute (CGTI), Research Institute for Future Medicine, Seoul 06351, Korea.
  • Hwang JW; Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul 06351, Korea.
  • Sa JK; Samsung Medical Center, Cell and Gene Therapy Institute (CGTI), Research Institute for Future Medicine, Seoul 06351, Korea.
  • Son HJ; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul 06351, Korea.
  • Kim HJ; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul 06351, Korea.
  • Jang H; Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02841, Korea.
  • Chang JW; School of Medicine, Sungkyunkwan University, Suwon 16419, Korea.
  • Na DL; Samsung Medical Center, Cell and Gene Therapy Institute (CGTI), Research Institute for Future Medicine, Seoul 06351, Korea.
Biomedicines ; 10(8)2022 Aug 04.
Article in En | MEDLINE | ID: mdl-36009433
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomedicines Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomedicines Year: 2022 Document type: Article